PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Dec '20 Jun '20 Mar '20 Dec '19 Older periods
P/E ratio
— 0.00 0.00 0.00

+8 more quarters

P/S ratio
— 6.02 4.93 7.04
P/FCF ratio
— 0.00 4.66 5.49
P/Operating CF
— (15.43) (17.48) (20.14)
P/B ratio
— 0.74 0.48 0.65
EV/Sales
— 4.24 2.86 4.45
EV/EBITDA
— 0.00 0.00 0.00
EV/FCF
— (32.11) 2.70 3.47
Current Ratio
— 13.68 13.21 6.87
Net Debt/EBITDA
— 7.25 3.67 1.61
Debt/Equity
— 0.03 0.02 0.05
Earnings Yield
— (49.44%) (43.32%) (19.38%)
Free Cash Flow Yield
— (2.20%) 21.48% 18.23%
Free Cash Flow per Share
— (0.18) (0.12) 0.01
Book value per Share
— 3.62 4.50 5.00
Free Cash Flow
— (20.35) (15.35) 1.58
EV/EBIT
— 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates